<DOC>
	<DOCNO>NCT00619801</DOCNO>
	<brief_summary>The purpose study determine safety oral formulation levocetirizine child age 1 less 6 year old suffer allergic rhinitis chronic urticaria unknown origin .</brief_summary>
	<brief_title>Safety Study Levocetirizine Dihydrochloride Oral Liquid Formulation Children Aged 1 Less Than 6 Years Suffering From Allergic Rhinitis Chronic Urticaria Unknown Origin</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Outpatient , male female pediatric subject , age 1 less 6 year old Randomization Visit ( V2 ) ( 1 &lt; 6 year old ) The subject must present least one follow symptom , commonly associate allergic rhinitis chronic urticaria : nasal itching , sneeze , rhinorrhea , nasal congestion , tear , eye redness itch eye , ear and/or palate , skin wheal itch skin Subjects ( age 2 less 6 year ) suffer allergic rhinitis ( AR ) document allergy measure positive skin prick test RAST ( Radioallergosorbent Test ) perform within last 6 month prior randomization Candidate antihistamine treatment receive antihistamine past similar symptom present Caregiver ( ) inform nature aim study give write informed consent subject participate study Caregiver ( ) able understand information give , text informed consent , able complete daily record card ( DRC ) Any clinically significant medical condition abnormality primary diagnosis antihistamine indicate Be initiate change dose immunotherapy regimen course study ( Visit 1 Visit 4 ) Any electrocardiogram ( ECG ) parameter , include QTcF interval &gt; 443 msec measure ECG obtain Screening Visit , outside normal reference range Any clinical laboratory test perform Screening Visit , related allergic condition , outside reference range . Subjects value outside accept reference range include Investigator 's opinion , clinical significance Personal history seizure , febrile seizure sleep apnea Below lower 5th 95th percentile body weight and/or height base upon CDC Growth Charts Body Weight Length Allergy intolerance levocetirizine dihydrochloride excipients , piperazine derivative , hydroxyzine , cetirizine , cyclizine , meclozine , buclizine Current past intake follow medication ( include exposure breast milk ) within specify washout period Randomization Visit ( V2 ) : 1 . Systemic corticosteroid within past 28 day 2 . Leukotrienereceptor antagonist ( e.g . montelukast [ Singulair ] zafirlukast [ Accolate ] within past 7 day ) 3 . Mastcell stabilizer ( e.g . cromolyn nedocromil ) within past 7 day 4 . Other antihistamine cough cold preparation ( exception single ingredient guaifenesin product ) overthecounter ( OTC ) sleep aid medication within past 7 day 5 . Systemic antibiotic within past 7 day 6 . Other concomitant medication interfere study , opinion investigator Previous participation another clinical/pharmacological trial within past month prior V1 Have already participate study participate study another site Children member study site staff</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Xyzal</keyword>
	<keyword>Levocetirizine</keyword>
	<keyword>Allergy</keyword>
	<keyword>Children</keyword>
	<keyword>Seasonal Allergies</keyword>
</DOC>